IRCT2017072834482N2招募中3 期
A comparative study of escitalopram ,placebo and relaxation on hot flashes of patients with breast cancer
Vice chancellor for Research, Kermanshah University of Medical Sciences0 个研究点目标入组 87 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 87
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- Female
入选标准
- •having at least 4 hot flash attacks daily; Age range is 18 to 65 years; a history of breast cancer; not in acute phase of breast cancer, Ability to read and write and being able to answer questions ;Consent to participate in the study; Not concurrent using of any drugs that affect hot flash symptoms such as gabapentin, pregabalin, clonidine, SSRIs, herbal drugs and other treatments such as acupuncture, hypnotism ; no Non-malignant hypertension or CVA or MI or other uncontrolled organic problems and psychotic or bipolar disorders
- •Exclusion criteria: incidence of intolerable drug side effects, breast cancer relapse needing chemotherapy
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
招募中
3 期
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
终止
4 期
Wellness StudyChronic illness - patients who are generally unwell for an extended period.Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12608000398303Mood Research Foundation (WA)50
已完成
不适用
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorderJPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200
进行中（未招募）
1 期
A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo, and standard psychological care, for depression in Parkinson’s diseaseDepression in Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002942-35-GBniversity College London Comprehensive Clinical Trials Unit408